Genetic analysis of Drosophila eye development revealed a link between Kuzbanian, also known as ADAM10, and Notch signaling (see references cited in refs. 8, 9) . Further studies using the same organism implicated ADAM10 in Notch shedding 15 . In mice, Adam10 gene deletion resulted in phenotypes similar to those associated with impaired Notch signaling 16 . Therefore, ADAM10 has been considered to be a major sheddase of Notch in mice. However, recent studies in mice have yielded no evidence for a physiological role for ADAM10 in Notch shedding [16] [17] [18] . Taken together, these various studies suggest that the activity of ADAM10 is instead necessary for the shedding of Notch ligands; thus in mammals, ADAM10 influences Notch signaling principally in a noncell autonomous manner. Moreover, ADAM17 (also known as tumor necrosis factor a-converting enzyme) has been implicated in Notch signaling 17, 18 . Notably, the phenotype of Adam17-deficient mice appeared to be unrelated to Notch signaling (see references cited in refs. 8, 9) . However, this finding may not be sufficient to completely eliminate ADAM17 from the list of prospective mammalian Notch sheddases. Both the unique function of ADAM17 in epidermal growth factor-receptor activation 19 and the functional redundancy it shares with other ADAM proteins 20 may have masked the manifestation of Notch-related phenotypes in Adam17-deficient mice.
In the mammalian CNS, ADAM10 is expressed in a wide variety of neural cells throughout the developmental stages 21 . In contrast, the NPC proliferation that is reportedly regulated by Notch signaling occurs in a spatiotemporally regulated manner during embryonic brain development 22 . Given that ADAM10 is implicated in Notch signaling, by what mechanism is ADAM10 activity exquisitely regulated during embryonic development? Tissue inhibitor of metalloprotease (TIMP) 1 and TIMP3 can inhibit ADAM10 activity in vitro; however, there is no in vivo evidence for such activity 9, 23 . Timp3 deficiency induces chronic liver inflammation associated with abnormal tumor necrosis factor activity 24 , which may be due to the functional interaction with ADAM17. In addition, none of the TIMP proteins have been implicated in Notch signaling to date 23 .
RECK has thus far been implicated in the regulation of the cell surface activity of matrix metalloproteinase (MMP) 9, MMP2, membrane type-1 matrix metalloproteinase (MT1-MMP) and CD13/ aminopeptidase N [25] [26] [27] . Clinical relevance of RECK has been observed in many types of cancers and chronic inflammatory diseases, for example, the lower RECK expression in primary tumors is associated with poor prognosis (see references cited in ref. 28) . RECK shares many functional similarities with those TIMPs 23 that can inhibit the proteolytic activity of many types of ADAMs 9 and MMPs. In addition, as its unique cell surface topology imparted by glycosylphosphatidylinositol anchoring is believed to facilitate an increased accessibility to the membrane proteins 25 , it has been postulated that RECK shares a certain functional relationship with the ADAM proteins.
We have previously reported the expression of a vascular phenotype in Reck-deficient embryos that was only partially rescued by the simultaneous deletion of Mmp2 (ref. 26) . We recently noticed that this vascular phenotype was extremely similar to that expressed in mouse embryos with impaired Notch signaling (see references cited in ref. 4) . Here, we provide evidence that Reck deficiency leads to the downregulation of Notch signaling in NPCs. These findings prompted us to identify the metalloprotease that is involved in Notch signaling and simultaneously targeted by RECK. Here we demonstrate, with genetic and biochemical evidence, that RECK is a physiological inhibitor of ADAM10. Through this function RECK controls the activity of ADAM10, whose deregulated activation shuts down Notch signaling via excess shedding of Notch ligands.
RESULTS

Developmental expression of RECK in CNS
To explore the role of RECK in brain development, we stained sectioned embryonic mouse CNS at various developmental stages by using a monoclonal antibody specific for RECK 25 . RECK was expressed specifically in Nestin 29 -positive cells in the CNS on embryonic day 10.5 (E10.5) and E14.5 (Fig. 1a) . At postnatal day 1 (P1), the RECK and Nestin signals still tightly overlapped and were confined to the subventricular zone where neural cells with proliferative potential are maintained at this stage 7 (Fig. 1a) . Even in more aged mice, RECK expression was detected in Nestin-positive cells residing in hippocampus and subvetricular zone of cerebrum (data not shown). We used immunoblotting to determine the expression of RECK and Nestin in wild-type embryonic mouse CNS at different developmental stages. Our immunoblotting results completely coincided with our immunofluorescence results, assuring the specificity of signals displayed in the immunofluorescence study (Fig. 1b) .
Neural phenotypes in Reck-deficient mouse embryo Mice lacking Reck die at mid-gestation (E10.5 or later), because of abruptly occurring intra-abdominal hemorrhage that likely stems from abnormal vascular development 26 . We addressed whether any other developmental defects can be detected in Reck-deficient embryos before the time of lethality. We discovered that the expression pattern of a neuron-specific marker (type III b-tubulin, TuJ1) 30 in the CNS was remarkably perturbed in E10.0 Reck -/-live embryos (Fig. 2a) . A large population of neural cells in the Reck -/-CNS abnormally expressed the neuronal differentiation marker TuJ1 in the internal and subventricular zones, where TuJ1 is normally not expressed during corticogenesis. The ratio of TuJ1-positive cells to the DAPI signal (nuclei) was quantified from the observation of five embryos of each genotype. The frequency of TuJ1-positive cells in the Reck -/-CNS was 5.3 ± 0.6-fold (s.d., P o 0.001) higher than that in the wild-type CNS (Fig. 2a) , suggesting that there was an acceleration of neuronal differentiation. These spatially abnormal TuJ1-positive cells very likely had already undergone terminal differentiation, because they neither expressed Nestin (Fig. 2a) nor incorporated 5-bromodeoxyuridine (BrdU) (Fig. 2b) . Thus, we conclude that Reck deficiency induces precocious differentiation of NPCs during embryonic cortical development.
Impaired Notch signaling in Reck-deficient CNS We noticed that phenotypic abnormalities appearing in the Reck -/-CNS and vascular system 26 were extremely similar to those found in mice with impaired Notch signaling 3, 4 . Notably, we observed that the abundance of active Notch1 was decreased in the Reck -/-CNS (Fig. 2c) . Consequently, expression of the transcriptional targets of the Notch signal (Hes1 and Hes5) 26 was specifically downregulated in the E10.0 Reck -/-CNS. Reciprocally, the markers of neuronal differentiation (Neurog1 and Neurod1) were upregulated (Fig. 2d) . These findings indicate that Reck deficiency causes impaired Notch signaling in the mouse embryonic CNS. Defective self-renewal in Reck-deficient NPCs To further address the mechanism of precocious neuronal differentiation associated with the loss of Reck, we analyzed the neural cells derived from the mechanically disaggregated CNS of E10.0 Reck -/-live embryos. The wild-type and Reck -/-neural cells were equally viable as assessed by trypan blue exclusion test and TUNEL (data not shown). However, Reck -/-neural cells failed to form spherical structures (neurospheres) when growing on nonadherent dishes in the presence of fibroblast growth factor 2 (FGF2) 31 (Fig. 3a) . This phenotype was partially, but significantly (P o 0.01), reversible by the retroviral introduction of either wild-type RECK (Fig. 3b) or constitutively active Notch1 (ref. 6) (Fig. 3c) . As it was demonstrated that the simultaneous deletion of Mmp2 very partially rescued the lethality in Reck -/-embryos 26 , we examined whether the simultaneous deletion of Mmp2 and Mmp9 could rescue the precocious differentiation that occurs in Reck -/-CNS. There was no obvious rescue ( Supplementary  Fig. 1 online) , and in addition, there have been no signs of Notch-related phenotypes in any of MMP2-, MMP9-and MT1-MMP-deficient mouse embryos in previous reports [32] [33] [34] . This suggests that the deregulation of a yet unidentified RECK target may occur. If so, it may account for the neural phenotypes observed in Reck -/-embryos.
Rescue of Reck-deficient phenotypes in vitro Because ADAM10 and ADAM17 are metalloproteases that are considered to be involved in the regulation of Notch signaling 8, 9 , we subsequently examined the effects of synthetic metalloprotease inhibitors (hydroxamates) that have differential specificities for these ADAMs 35 . GW280264X, which inhibits both ADAM10 and ADAM17, completely blocked neurosphere formation by both wildtype and Reck -/-NPCs. In contrast, GI254023X , which preferentially inhibits ADAM10, but not ADAM17, significantly rescued the defective neurosphere formation associated with the loss of Reck ( Fig. 3d , P o 0.01). These findings indicate that ADAM10 may mediate Reck deficiency to affect the self-renewal of NPCs.
In the above experiment, all treatments failed to achieve full rescue of the defective neurosphere formation of Reck -/-neural cells. The primary reason for this could be that a substantial population of Reck -/-NPCs were already terminally differentiated, and therefore could not be rescued. Another caveat to be considered regarding the use of Reck -/-NPCs is the secondary (non-cell autonomous) effects of vascular malformation found throughout the embryonic body 26 (for example, hypoxia). These factors motivated us to use the normal NPCs prepared from wild-type E10.5 embryos to assess the effects of gene knockdown using an RNA interference technique. We observed that the depletion of RECK in these cells was sufficient to reduce the population of Nestin-positive and BrdU-incorporating cells, and reciprocally to increase that of TuJ1-positive cells (Fig. 4a,b and Supplementary Fig. 2  online) . Notably, the additional depletion of ADAM10, but not ADAM17, antagonized the effect of RECK depletion at a level comparable to that obtained by the enhancement of Notch signaling (Fig. 4 and Supplementary Fig. 2 ). To exclude the possibility that these results were derived from off-target effects of the short hairpin RNAs (shRNAs) that we used, we repeated the same experiment using multiple combinations of completely different sets of shRNAs targeting independent RNA sequences, together with two sets of shRNAs specific for EGFP as RNA-induced silencing effector complex-inducible negative controls. All the results obtained by these experiments were completely consistent with each other ( Supplementary Fig. 3 online) , suggesting that the off-target effects of shRNAs were negligible in all of our observations.
Rescue of Reck-deficient phenotypes in vivo
To demonstrate the in vivo relevance of our observations from our in vitro neurosphere assays using RNA interference, we transduced shRNA expression vectors targeting RECK or ADAM10 into E12.5 CNS by in utero electroporation from the telencephalic vesicle, and examined the resultant telencephalon (forebrain) at E15.5. The shRNAintroduced regions were marked by a co-introduced EGFP expression vector (16.6% of the total injected DNA). Notably, the introduction of RECK shRNAs markedly induced the indicator of precocious differentiation in the CNS: that is, spatially abnormal TuJ1 expression in the ventricular and subventricular zones, in a mosaic manner (Fig. 5) . Furthermore, co-electroporation of ADAM10 shRNAs efficiently rescued the spatially abnormal TuJ1 expression induced by RECK shRNAs (Fig. 5) . The possibility of off-target effects of the shRNAs was again carefully excluded ( Fig. 5 and Supplementary  Fig. 4 online).
ADAM10-dependent Delta shedding in RECK-depleted NPCs
After observing the in vivo rescue of Reck deficiency by ADAM10 depletion, we turned again to the cultured wild-type NPCs in which RECK was depleted. We found that RECK depletion significantly promoted the ectodomain shedding of the Notch ligand Delta; this phenomenon was closely associated with the reduced expression of Nestin. Moreover, the effect was almost completely antagonized by the simultaneous depletion of ADAM10 (Fig. 6a) . To examine the specificity of the relationship between RECK and ADAM10 in the regulation of Delta shedding, we observed the effect of simultaneous depletion of ADAM17, which is another member of the ADAM family and known to be involved in Notch signaling; this did not antagonize the effect of RECK depletion on Delta shedding (Fig. 6b) . The possibility of offtarget effects of the shRNAs that we used was again carefully examined ( Fig. 6b and data not shown) . Together, these findings suggest that Reck deficiency promotes the ectodomain shedding of Delta in NPCs specifically in an ADAM10-dependent manner.
Direct inhibition of ADAM10 activity by RECK Next, we assessed the effect of RECK gain of function on ADAM10-dependent Delta shedding. ADAM10 overexpression promoted the ectodomain shedding of the hemagglutinin (HA)-tagged Delta1 that we exogenously introduced into Cos1 cells; this was blocked by the coexpression of RECK (Fig. 7a) . Reck -/-mouse embryonic fibroblasts Different sets of shRNAs were tested to assess their off-target effects (see also Supplementary Fig. 3 ).
(MEFs) expressed a considerable amount of endogenous ADAM10. Consequently, we observed ADAM10-dependent abnormal shedding of Delta1 and Jagged1 in these cells. The re-expression of RECK attenuated the abnormal shedding of these molecules (Fig. 7b and data for Jagged1 not shown).
To further examine the specificity of the relationship between RECK and ADAM10 in the regulation of Delta shedding, we examined whether ADAM17 promoted Delta shedding in our conditions, and if so, whether it was blocked by RECK. The result indicated that under the same experimental condition as used for ADAM10, ADAM17 did not promote Delta shedding ( Supplementary Fig. 5 online) . In addition, we observed that the shedding of exogenous Delta1 that occurred in Reck -/-MEFs did not depend on ADAM17 (Supplementary Fig. 5 ). Therefore, we did not examine the relationship between RECK and ADAM17 any further in the present study. It has been recently reported that ADAM9 and ADAM12 are capable of shedding Delta1 (ref. 36). We did not focus on ADAM9 and ADAM12, as knockout mice did not have an abnormal CNS phenotype (see references cited in refs. 8,9), but we did examine whether RECK can inhibit Delta shedding induced by ADAM12. Our result indicated that RECK does not inhibit ADAM12-induced Delta shedding, at least in NIH 3T3 cells ( Supplementary  Fig. 5 ). These findings indicate that ADAM12 is unlikely to be overactivated in the Reck-deficient embryonic CNS, and that RECK has a certain specificity in its inhibition of ADAMs.
We found that a soluble RECK mutant, lacking the GPI anchor domain, can attenuate Delta1 shedding ( Supplementary Fig. 6 online) . This finding suggested to us that RECK may function as a direct ADAM10 inhibitor even in a soluble form. To test this hypothesis, we first determined that ADAM10 and RECK physically associated with each other by immunoprecipitation (Fig. 7c) . Second, we observed that the recombinant soluble RECK (rRECK) inhibited the ability of recombinant soluble ADAM10 (rADAM10) to process the purified thioredoxin-fused Delta1 (367-521) (TDEL) in a dose-dependent manner (Fig. 7d) . Finally, we determined that rRECK blocked rADAM10 from degrading a synthetic substrate with IC 50 at 10.2 nM (K i o 15 nM). In our current conditions, however, the manner of rADAM10 inhibition seemed to be noncompetitive (data not shown), unlike the competitive manner in which rRECK inhibits its known targets [25] [26] [27] . By using the ultrasensitive gelatin zymography technique, we detected extremely low levels of gelatinolytic activities (B28/19 kDa) in the final rRECK product, which was probably due to their affinities for RECK (data not shown). Although the experiments using transfected cells and TDEL convinced us of ADAM10 inhibition by RECK, there remains a possibility that these copurified protease activities might have slightly modified the readout of our kinetic assays using a synthetic substrate. A complete purification of rReck may be necessary for determining of the manner of the inhibition kinetics.
Because previous reports indicated that ADAM10 is involved in the ectodomain shedding of Notch 15 , as well as Delta, in Drosophila, we transfected Reck -/-MEFs with a mutant form of Notch1, Notch1DE 37 , that undergoes ADAM activity-dependent ectodomain shedding without binding to its ligands, and assessed the effect of RECK re-expression on it. We observed a certain amount of shed (active) Notch1 in these cells; however, the re-expression of RECK did not influence the degree of Notch1 activation ( Supplementary Fig. 7 online) , suggesting that RECK influences the ADAM10-dependent shedding of Notch ligands, rather than of the Notch receptor in the tested murine cells. This observation is consistent with reports from other groups that found no evidence of ADAM10 affecting Notch shedding in murine cells [16] [17] [18] . 
RECK supports the intercellular Notch signaling
Thus far, we had investigated the mechanism by which RECK controls ADAM10-dependent Notch ligand shedding using a homogeneous cell population. To examine the role of RECK in the intercellular communication system involving Notch, we cocultured Reck -/-MEFs expressing Delta1 with or without RECK (effector cells) and NIH 3T3 cells transfected with intact Notch1 and a reporter construct for detecting Notch signaling (CBF1-luc; reporter cells) 38 , and subsequently measured the luciferase activity in the reporter cells 39 . The results indicated that effector cell-expressed RECK enhanced Delta1-induced Notch signaling in the reporter cells (Fig. 8) . Furthermore, ADAM10 depletion in the effector cells had an effect comparable to that of RECK reexpression (Fig. 8) . In contrast, RECK overexpression in the reporter cells did not influence intercellular Notch signaling ( Supplementary  Fig. 8 online) . These findings suggest that RECK supports intercellular Notch signaling system by controlling the ADAM10-mediated shedding of Notch ligands. This notion is consistent with the current theory that Delta1 cleavage is instrumental for downregulating the Notch signal [10] [11] [12] [13] [14] .
DISCUSSION RECK has been recognized as a modulator of the extracellular milieu that critically influences embryonic development and tumor progression. This function of RECK was initially attributed to its functional interaction with MMPs 25, 26 . However, this conventional view does not sufficiently explain the organ-or cell lineage-specific phenotypes in Reck-deficient mice. Here we demonstrated that RECK specifically targets Notch signaling by directly interacting with ADAM10 in NPCs. Nonetheless, from the classic viewpoint, spatially abnormal TuJ1 expression in Reck -/-CNS could be explained by abnormal cell migration in NPCs induced by deregulated MMP activities and following perturbation in integrin signaling. We do not exclude this possibility. In this study, because of the markedly increased number of TuJ1-positive cells in Reck -/-CNS and the increased expression of proneural markers ( Fig. 2d; that is, the evidence of increased differentiation), we focused on precocious differentiation instead of cell motility. In addition, we have found no evidence of disturbed integrin signaling in Reck-deficient CNS to date (T. Muraguchi and C.T., unpublished data). None of the MMP2 -/-(ref. Fig. 1 ). In contrast, MMP2 deletion was sufficient only to rescue abnormal type-I collagen metabolism 26 . Therefore, we did not address the involvement of MMPs in the present study.
The structural basis by which RECK inhibits MMPs and ADAM10 is currently under intensive investigation. We are in the process of determining the domains of RECK that are accessed by target proteases, and identifying new metalloproteases binding to RECK (ref. 27 ). Furthermore, we recently reported that RECK modulates the endocytic pathways of its target membrane metalloproteases 27 , suggesting that RECK-target protease binding is not solely used for suppressing their proteolytic activities. It is of great interest to address whether RECK modulates the behavior of ADAM10 on the cell surface as well as inhibits its proteolytic activity. Nestin is one of the few markers of NPCs. It is important to note that RECK appeared to function upstream of Nestin in NPCs. Furthermore, this study proposes that RECK is one of the most upstream modulators of Notch signaling. From this viewpoint, it is important to investigate the mechanism of developmental expression of RECK. Notch signaling is implicated in multiple stem cell systems. Whether RECK influences the stem cell activity of multiple lineages through its influence on Notch signaling or ECM remodeling, or via other signaling systems, will be of great interest. A previous study indicated that Reck -/-MEFs possess increased susceptibility to differentiate to myocytes when transduced with exogenous MyoD 41 ; this might be attributed to the effect of RECK on Notch signaling during myogenesis. The possibility that the appearance of a vascular phenotype in Reck -/-embryos is due to the deregulated Notch signaling is currently under intensive investigation. Simultaneously, we hypothesize that the defective angiogenesis observed in tumors overexpressing exogenous RECK 26 might be related to the intercellular Notch signaling between tumor and vascular endothelial cells 42 . Furthermore, Notch signaling has been linked to epigenetic gene silencing and cell cycle control during tumorigenesis in Drosophila 43 . Because RECK expression is suppressible by various oncogenic signals 25 , and its overexpression partially antagonized Ras transformation 25 , we speculate that the ADAM10-RECK-Delta-Notch system might be profoundly involved in the processes of tumorigenesis and progression.
ADAM10 is implicated in many biologically important shedding events other than Delta shedding: for example, shedding of amyloid precursor protein, CX3CL-1, CXCL-16, betacellulin, pro-epidermal growth factor, pro-heparin-binding EGF-like growth factor, proTNFa, interleukin 6 receptor, CD44, L1, b secretase 1, ephrin-A2, prion protein, Slit, collagen XVII (refs. in 9), N/E-cadherin 44, 45 and CD23 (ref. 46 ). For instance, ADAM10 is considered to be one of the a-secretases of amyloid precursor protein. This activity reduces the formation of b-amyloid protein, whose deposition in the brain is responsible for a type of familial Alzheimer's disease in adults (refs. in 8) . Recently, it has been indicated that ADAM10 may contribute to allergic reactions by shedding the low-affinity IgE receptor CD23 (ref. 46) . A determination of whether the RECK expression is deregulated in clinical contexts such as Alzheimer's disease or allergy would be of interest.
Another issue that must be addressed in the future is the specificity of the interaction between RECK and ADAM10. Because of functional redundancies in ADAMs 20 and in the known soluble inhibitors represented by TIMPs 9 , it is possible that RECK interacts with other members of the ADAM family. Currently, this hypothesis is under intensive investigation.
METHODS
Mice. Reck +/-mice 26 were backcrossed to C57BL/6 mice for seven generations and intercrossed for timed pregnancy. Animals were handled in accordance with the guidelines of Kyoto University.
Immunofluorescence analysis and immunoblotting. The following primary antibodies were used: mouse anti-RECK IgG 2a 25 , mouse anti-Nestin IgG 1 (401, Chemicon), mouse anti-type III b tubulin IgG 2a (TuJ1, Covance) labeled with Alexa Fluor 488 or 568 (Zenon Alexa Fluor Mouse IgG Labeling Kit, Invitrogen), rabbit anti-EGFP conjugated with Alexa Fluor 488 (A21311, Invitrogen), rabbit anti-ADAM10 (Ab-1, Calbiochem), rabbit anti-ADAM17 (AB19027, Chemicon), mouse anti-a tubulin (DM1A, Sigma), and mouse anti-HA (12CA5, Roche). Incorporated BrdU and active Notch1 were estimated as described previously 22 .
RT-PCR. The sense and antisense primers used are listed in Supplementary  Table 1 online.
Neurosphere assays. E10.0 whole brain was mechanically dissociated as described previously 31 , and cultured as a suspension (1.0 Â10 4 cells per ml) in Dulbecco's modified Eagle's medium (DMEM)/F12 supplemented with B27 (Invitrogen) in the presence of 20 ng ml -1 FGF2 (Peprotech). The number of neurospheres was counted after 7 d of incubation. For staining and immunoblotting, cells prepared in the same manner were plated onto poly-D-lysinecoated coverslips or dishes at a density of 4 Â 10 5 cells cm -2 , infected with retrovirus or shRNA adenovirus, and cultured for 4 d.
Retrovirus and plasmids. Retroviruses were recovered from EcoPak293 (Clontech) cells transfected with pLXSB or pLXSB-hRECK 41 , or from C2mp34 cells transfected with 1726AP-caNotch1 (ref. 6). The virus titer was estimated by observing the gain of blasticidin resistance or activation of CBF-1-luc reporter 38 in the infected NIH 3T3 cells. The estimated multiplicity of infection was approximately 2-3. The neural cells were prepared in the same way as the neurosphere assays, plated 5 h before infection and infected with virus suspension in the presence of 8 mg ml -1 polybrene and 20 ng ml -1 FGF2. Cells were transfected with pBos-SN3T-Delta1-HA 14 , pME18S-ADAM10 (a gift from E. Nishi, Kyoto University), pcDNAI-Notch1 47 , pEF-Bos-Notch1DE 48 , GL2pro-CBF1-luc 38 or pLXSB-FLAG-RECK 27 using Fugene 6 transfection reagent (Roche). pLXSB-FLAG-RECK expresses human RECK with a FLAG (PTMDYKDDDDK) epitope inserted between 27G and 29D 27 .
RNA interference. The pAd/BLOCK-iT-DEST system (Invitrogen) was used for adenoviral introduction of shRNA. The sequences of the shRNA templates are indicated in Supplementary Table 2 online.
In utero electroporation. We injected 5 mg of the shRNA expression vectors (pENTR/U6; Invitrogen) with 1 mg of pEF-EGFP 49 through the uterine wall into the telencephalic vesicle of each embryo in utero at E12.5. The sequences of the shRNA templates are indicated in Supplementary Table 2 . The injected expression vectors were introduced into the ventricular zone cells in the dorsolateral telencephalon using five square pulses generated by a square electroporator CUY21 EDIT (TR Tech) as described previously 49 . Embryos were harvested 72 h after electroporation.
Detection of Delta N-terminal fragment. Wild-type E10.5 NPCs plated on poly-D-lysine-coated dishes were cultured in medium for the neurosphere assay and infected with shRNA adenovirus. The cells were then cultured for 18 h in methionine-free DMEM containing 1.85 MBeq ml -1 [ 35 S] methionine. The culture media were immunoprecipitated using goat anti-Delta antibody (F-15; Santa Cruz Biotechnology).
Immunoprecipitation. The cells were lysed in 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, 10% glycerol, 1% Triton X, 1.5 mM MgCl2, 1 mM EDTA and 1Â protease inhibitor cocktail (03969-21, Nacalai tesque). Lysates were immunoreacted with rabbit anti-FLAG polyclonal antibody (F7425, Sigma) or rabbit anti-ADAM10 polyclonal antibody (Ab-1, Calbiochem).
Recombinant soluble RECK and TDEL. Culture supernatants were recovered from 293F cells transfected with pCXN2-hRECK(1-942)-6xHis 27 . BL21 E. coli transduced with pET102/D-TOPO-Delta1(367-521) (vector, Invitrogen) expressed a portion of rat Delta1 (TDEL) containing a site cleaved by ADAM10 50 , fused with thioredoxin at its N terminus and 6xHis at its C terminus. Both products were purified using a Hi-trap chelating column (GE Healthcare) and FPLC (Bio-Rad). The purity of both materials was approximately 97%. Anti-Thio antibody (R920-25, Invitrogen) detected the thioredoxin fragment.
ADAM10 assay. We mixed 769 ng of ADAM10 (18-672) (936-AD, R&D) with various concentrations of the peptide Mca-K-P-L-G-L-dpa-A-R-NH 2 (1-20 mM; ES010, R&D) and recombinant soluble RECK protein (0-1.35 nM) in 200 ml of assay buffer containing 100 mM Tris-HCl (pH 8.0), 80 mM NaCl, 10 mM CaCl 2 , 10 mM ZnCl 2 , 0.1% Brij-35 and 0.1% PEG 6000. The output signal (excitation wavelength, 325 nm; emission wavelength, 393 nm) was recorded using SPECTRAmax (Molecular Devices).
